Incyte Genomics Inc
A$136.37
AUD
Last updated on --.
24h volume729.05K
24h highest138.39 AUD
24h lowest134.88 AUD
24h Price movement+0.30%
INCY recent prices
24 Hours
+0.30%+A$0.40609
30 days
+0.40%+A$0.54192
60 days
+8.63%+A$10.91
90 days
-3.10%-A$4.402
Key data
Previous close135.97 AUD
Market cap27.16B AUD
Volume729.05K
P/E ratio13.550000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)10.0402 AUD
Net income (FY)2.00B AUD
Revenue (FY)7.51B AUD
Last report date28 Apr 2026
About Incyte Genomics Inc
HeadquartersWILMINGTON
Employees (FY)2.84K
Revenue per employee (FY)2.64M AUD
Net income per employee (FY)704.96K AUD
Listed onNasdaq
INCY conversion tables
 |  |
|---|---|
| 0.5 INCY | 68.18 AUD |
| 1 INCY | 136.37 AUD |
| 5 INCY | 681.87 AUD |
| 10 INCY | 1,363.75 AUD |
| |
|---|---|
| 0.5 AUD | 0.0036664 INCY |
| 1 AUD | 0.0073327 INCY |
| 5 AUD | 0.036664 INCY |
| 10 AUD | 0.073327 INCY |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
INCY is trading at A$136.37, +0.30% over the last 24 hours. Track live moves on the price chart at the top of this page.
The INCY stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. INCY is currently trading at A$136.37, +0.30% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on INCY price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. INCY's P/E ratio is currently 13.550000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from INCY; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against INCY's historical range and other companies in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector.
Incyte Genomics Inc's market cap is currently 27.16B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume729.05K
24h highest138.39 AUD
24h lowest134.88 AUD
24h Price movement+0.30%
Start trade with INCY Perpetual
Sign up to trade